BioLife Solutions BLFS
Valuation
Multiples measured against the stock's own five-year history
Near the top of its 5-year range · 92nd percentile, 5-year average -61.5x
#2208 of 2969 stocks by PE (1 = cheapest)
Near the top of its 5-year range · 99th percentile, 5-year average 2.8x
#4230 of 5318 stocks by PB (1 = cheapest)
Near the top of its 5-year range · 97th percentile, 5-year average 9.0x
#4673 of 5149 stocks by PS (1 = cheapest)
P/E over five years
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 4.50 | – | 2.78 | 99% (pricier than usual) | #4230 of 5318 (1 = cheapest) |
| PE | 32.72 | 145.10 | -61.50 | 92% (pricier than usual) | #2208 of 2969 (1 = cheapest) |
| PS | 17.71 | 15.31 | 9.03 | 97% (pricier than usual) | #4673 of 5149 (1 = cheapest) |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on BLFS.
Sign in to join the discussion.